Channelopathy: Difference between revisions
(No difference)
|
Revision as of 18:51, 2 January 2009
WikiDoc Resources for Channelopathy |
Articles |
---|
Most recent articles on Channelopathy Most cited articles on Channelopathy |
Media |
Powerpoint slides on Channelopathy |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Channelopathy at Clinical Trials.gov Trial results on Channelopathy Clinical Trials on Channelopathy at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Channelopathy NICE Guidance on Channelopathy
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Channelopathy Discussion groups on Channelopathy Patient Handouts on Channelopathy Directions to Hospitals Treating Channelopathy Risk calculators and risk factors for Channelopathy
|
Healthcare Provider Resources |
Causes & Risk Factors for Channelopathy |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Channelopathies are diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. These diseases may be either congenital (often resulting from a mutation or mutations in the encoding genes) or acquired (often resulting from autoimmune attack on an ion channel).
There are a large number of distinct dysfunctions known to be caused by ion channel mutations. The genes for the construction of ion channels are highly conserved amongst mammals and one condition, hyperkalemic periodic paralysis, was first identified in the descendants of Impressive, a pedigree race horse.
The channelopathies of human skeletal muscle include hyper-, hypo- and normokalemic (high, low and normal potassium blood concentrations) periodic paralysis, myotonia congenita and paramyotonia congenita.
Types
- Alternating hemiplegia of childhood
- Bartter syndrome
- Brugada syndrome
- Congenital hyperinsulinism
- Cystic fibrosis
- Episodic Ataxia
- Erythromelalgia
- Generalized epilepsy with febrile seizures plus
- Hyperkalemic periodic paralysis
- Hypokalemic periodic paralysis
- Long QT syndrome
- Malignant hyperthermia
- Migraine
- Myasthenia Gravis
- Myotonia congenita
- Neuromyotonia
- Nonsyndromic deafness
- Paramyotonia congenita
- Periodic paralysis
- Retinitis pigmentosa
- Romano-Ward syndrome
- Short QT syndrome
- Timothy syndrome
References
- Robert S. Kass (2005). "The channelopathies: novel insights into molecular and genetic mechanisms of human disease". Journal of Clinical Investigation. 115 (8): 1986&ndash, 1989. PMID 16075038.
Further reading
- Ashcroft F.M., Ion Channels and Disease. 2000. Academic Press.
- Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C & NewsomDavis J. 1997. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Annals OF Neurology 41(2):238-246 .
- Lehmann-Horn,F. & Jurkatt-Rott,K. 1999. Voltage-Gated Ion Channels and Hereditary Disease. PHYSIOLOGICAL REVIEWS 79(4).
- Newsom-Davis J, 1997. Autoantibody-mediated channelopathies at the neuromuscular junction Neuroscientist 3(5):337-346.